PHARMA & LIFE SCIENCES

Accelerating the future of life sciences and pharmaceuticals

Every life sciences and pharma breakthrough has the potential to change lives. And today, advances in AI, data and digital technologies are transforming how this industry discovers, develops and delivers the next generation of treatments.

Digital transformation in the pharmaceutical industry

The organisations leading this transformation will connect science, technology and operations to reduce complexity, accelerate development and bring better treatments to patients sooner. This requires trusted data, intelligent technology and the ability to move from innovation to implementation.

Talk to our Pharma & Life Sciences experts

Whatever your challenge, our specialists can help you find a clear way forward. Talk to us about what you want to achieve and how we can help make it happen.

Enquire now

Partner

Morten Just Blangsted

Life sciences and pharmaceuticals at a glance

$254 billion

AI has significant potential to transform the pharmaceutical industry, with estimates ranging from $60–110 billion in annual economic value for pharma and medical products from generative AI to $254 billion in additional annual operating profit by 2030 if AI is industrialised across the value chain. Realising that value depends on combining scientific expertise with trusted data, responsible AI and the ability to scale innovation.

Source: https://www.strategyand.pwc.com/de/en/industries/pharma-life-sciences/re-inventing-pharma-with-artificial-intelligence.html

AI

Pharmaceutical companies are increasingly investing in AI and advanced analytics as they move from experimentation towards enterprise-wide adoption.

Source: https://www.deloitte.com/us/en/insights/industry/life-sciences/ai-and-pharma.html

10-15 years

Bringing a new medicine to market typically takes 10–15 years, reinforcing the need to accelerate research, streamline clinical trials and modernise operations. Connected data and intelligent technologies can help reduce complexity and speed up the journey from discovery to patient care.

Source: https://phrma.org/policy-issues/research-development

Turning life sciences challenges into progress

Accelerate innovation with trusted data

Scientific breakthroughs depend on trusted, connected data. We help life sciences and pharmaceutical organisations integrate research, clinical and operational data, enabling faster discovery and better-informed decisions across the product lifecycle.

Scale AI with confidence

From drug discovery and clinical development to manufacturing and commercial operations, AI is reshaping every stage of the value chain. We help organisations identify high-value use cases, implement AI responsibly and scale innovation with confidence.

Modernise highly regulated operations

Innovation must be balanced with compliance, quality and patient safety. We help modernise technology, simplify processes and strengthen governance, enabling organisations to innovate faster while meeting regulatory expectations.

Improve performance from lab to patient

Delivering better patient outcomes requires more than scientific excellence. We help optimise operations across research, manufacturing and supply chains, improving efficiency and accelerating the journey from discovery to patient care.

INDUSTRIES